CARsgen® U.S. Clinical Holds Lifted by FDA ...Middle East

SHANGHAI, Oct. 31, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the U.S. Food and Drug Administration ("FDA") lifted the...

Read More Details
Finally We wish PressBee provided you with enough information of ( CARsgen® U.S. Clinical Holds Lifted by FDA )

Also on site :

• Palestinian activist Khalil denied release for son’s birth, wife says
• Pope Francis’s will in full: Pontiff’s final wishes and place of burial
• Education Ministry rehabilitates 70 schools since Assad regime’s fall